首页 | 本学科首页   官方微博 | 高级检索  
检索        

再生障碍性贫血患者T淋巴细胞早期激活及可溶性肿瘤坏死因子受体的研究
引用本文:申蓉,徐从高,李丽珍,张锑,秦雪梅,李杰,赵川莉.再生障碍性贫血患者T淋巴细胞早期激活及可溶性肿瘤坏死因子受体的研究[J].中华血液学杂志,2004,25(4):209-212.
作者姓名:申蓉  徐从高  李丽珍  张锑  秦雪梅  李杰  赵川莉
作者单位:250012,济南,山东大学齐鲁医院肿瘤中心血液研究室
基金项目:山东省自然科学基金资助项目 (Y2 0 0 2C0 7)
摘    要:目的研究再生障碍性贫血 (再障 )患者外周血CD4 、CD8 T淋巴细胞早期激活标志CD6 9的表达及血清、骨髓中可溶性肿瘤坏死因子受体 1和 2 (sTNF R1和sTNF R2 )的水平及其意义。方法将外周血在 2 0 μg ml植物血凝素 (PHA)条件下进行全血细胞培养 ,于 0h和 4h分别用双色免疫荧光标记流式细胞术对CD4 、CD8 T淋巴细胞CD6 9的表达进行分析。用ELISA法检测血清和骨髓中sTNF R1和sTNF R2的水平。结果PHA刺激前重型再障 (SAA)患者CD4 、CD8 细胞CD6 9的表达率增高 分别为 (8.96± 7.2 3) %和 (10 .6 7± 7.5 8) % ],慢性再障 (CAA)患者CD8 细胞CD6 9的表达率增高(7.36± 5 .4 9) % ];PHA刺激后再障患者CD4 、CD8 细胞表达CD6 9明显增强 SAA为 (71.73±11 91) %和 (6 1.74± 13.4 4 ) % ;CAA为 (5 9.35± 10 .15 ) %和 (4 8.78± 8.2 5 ) % ],CD4 细胞CD6 9的表达率高于CD8 细胞。SAA患者两种sTNF R水平均明显升高 sTNF R1血清为 (12 5 8.5 8± 385 .6 9)ng L ,骨髓为 (16 5 0 .6 0± 6 6 5 .0 1)ng L ;sTNF R2血清为 (12 5 7.10± 2 95 .4 9)ng L ,骨髓为 (2 0 73.5 7± 5 6 1.17)ng L]。CAA患者骨髓两种sTNF R水平升高 sTNF R1为 (10 94 .2 1± 2 91.93)ng L ,sTNF R2为 (15 0 2 .4 8±385 .5

关 键 词:贫血  再生障碍性  T淋巴细胞  抗原  表面  CD69  受体  肿瘤坏死因子
修稿时间:2003年4月25日

Study on the T lymphocytes early activation and soluble tumor necrosis factor receptor in patients with aplastic anemia
SHEN Rong,XU Cong-gao,LI Li-zhen,ZHANG Ti,QIN Xue-mei,LI Jie,ZHAO Chuan-li.Study on the T lymphocytes early activation and soluble tumor necrosis factor receptor in patients with aplastic anemia[J].Chinese Journal of Hematology,2004,25(4):209-212.
Authors:SHEN Rong  XU Cong-gao  LI Li-zhen  ZHANG Ti  QIN Xue-mei  LI Jie  ZHAO Chuan-li
Institution:Qilu Hospital of Shandong University, Jinan 250012, China.
Abstract:OBJECTIVE:To investigate the expression of T cell early activation marker (CD(69)) on peripheral CD(4)(+) and CD(8)(+) lymphocytes and serum levels of soluble tumor necrosis factor receptor 1 and 2 (sTNF-R1 and sTNF-R2) in serum and bone marrow in patients with aplastic anemia (AA) and their pathophysiological significance. METHODS: In vitro activation of T lymphocytes was carried out by whole blood cell culture containing PHA (20 micro g/ml). The CD(69) expressions on CD(4)(+) and CD(8)(+) lymphocytes at 0 h and 4 h after PHA exposure were analyzed by two-color flow cytometry. The levels of sTNF-R1 and sTNF-R2 in serum and bone marrow were measured by ELISA. RESULTS: The CD(69) expression rates of CD(4)(+) and of CD(8)(+) cells in SAA patients were (8.96 +/- 7.23)% and (10.67 +/- 7.58)%, respectively, and that of CD(8)(+) cells in CAA patients was (7.36 +/- 5.49)% before PHA stimulation. The CD(69) expression rates of CD(4)(+) and of CD(8)(+) cells in SAA patients were (71.73 +/- 11.91)% and (61.74 +/- 13.44)% and in CAA (59.35 +/- 10.15)% and (48.78 +/- 8.25)% respectively, and were significantly elevated after PHA stimulation. CD(69) expression on CD(4)(+) cells was much higher than that on CD(8)(+) cells after stimulation. The levels of the two sTNF-R (sTNF-R1 and sTNF-R2) in peripheral blood and bone marrow of SAA patients were elevated and in the bone marrow of CAA patients were also increased. The serum levels of sTNF-R2 were positively related to the CD(69) expression rates of CD(8)(+) cells before PHA stimulation. CONCLUSION: Increased early activation and activated potentials of T lymphocytes, along with abnormally elevated immunologically active molecules might play a major role in the pathogenesis of AA.
Keywords:Anemia  aplastic  Lymphocyte  Antigen  cell surface  CD69  Receptor  tumor necrosis factor
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号